About Lubrizol Life Science Health The Health business of Lubrizol Life Science (LLS Health) partners with customers to speed innovative medical devices and differentiated pharmaceutical products to market. Our pharmaceutical-grade carbomers, polycarbophils, and thermoplastic polyurethanes are used in a wide range of applications including sustained release oral solid dosage forms, semisolid and liquid formulations, transdermal applications and drug eluting device solutions. Our Carbopol?, Pemulen?, and Noveon? polymers have been successfully used in over-the-counter and pharmaceutical formulations to impart rheology modification, mucoadhesion, controlled drug release, and many other unique properties. As a CDMO, we excel in the formulation and manufacturing of complex drug products, including insoluble compounds, long-acting injectables/implantables, sterile products, highly potent APIs, and controlled substances. About The Lubrizol Corporation The Lubrizol Corporation, a Berkshire Hathaway Company, leverages its unmatched science to unlock immense possibilities at the molecular level, driving sustainable and measurable results. Founded in 1928, Lubrizol owns and operates more than 100 manufacturing facilities, sales and technical offices around the world and has approximately 8,600 employees. For more information, visit www.Lubrizol.com.